Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-02-04

Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Aripiprazole Administered With Lithium or Valproate Over 12 Weeks in the Treatment of Mania in Bipolar I Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial evaluated the efficacy and safety of adding aripiprazole to lithium or valproate for mania in Bipolar I Disorder; the study is completed with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ARIPIPRAZOLE (Aripiprazole)
  • Lithium carbonate (Lithium carbonate)
  • Valproate (valproate)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Bipolar Disorder Mania | Phase 3 | Status: COMPLETED | Results posted: 2013-02-04